Claire Exum, PA
Physician Assistant · Springfield, ORNPI 1053952648
Payments from drug & device makers
Across 229 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$758
- AstraZeneca$477
- Amgen$374
- Novo Nordisk$301
- GSK$275
- AbbVie$237
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,31499%
- Education$481%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 54 | $758 |
| AstraZeneca(2 entities) | 20 | $477 |
| Amgen(2 entities) | 18 | $374 |
| Novo Nordisk | 19 | $301 |
| GSK | 14 | $275 |
| AbbVie | 11 | $237 |
| Otsuka America Pharmaceutical, Inc. | 10 | $227 |
| Novartis | 10 | $216 |
| Boehringer Ingelheim | 7 | $192 |
| Lilly USA, LLC | 11 | $183 |
| Exact Sciences | 6 | $126 |
| Nestle Healthcare Nutrition Inc. | 5 | $100 |
| Xeris Pharmaceuticals, Inc. | 5 | $99 |
| Aimmune Therapeutics, Inc. | 4 | $77 |
| Johnson & Johnson | 3 | $77 |
| Dexcom, Inc. | 3 | $70 |
| Bristol Myers Squibb | 4 | $66 |
| Kowa Pharmaceuticals America, Inc. | 4 | $63 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Corcept Therapeutics | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Ultragenyx Pharmaceutical Inc. | 2 | $41 |
| Merck | 1 | $41 |
| Bayer | 2 | $33 |
| Edwards Lifesciences | 1 | $26 |
| Tandem Diabetes Care, Inc. | 1 | $22 |
| Radius Health, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Bioventus LLC | 1 | $15 |
How this compares
$4,362 in reported general payments places this provider in the 95th percentile of 1,756 physician assistant providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 35 | $36,193 |
| EliquisApixaban | 31 | $35,780 |
| FarxigaDapagliflozin Propanediol | 13 | $10,763 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $9,129 |
| Aripiprazole | 11 | $7,576 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,431 |
| Gabapentin | 75 | $2,982 |
| Levothyroxine Sodium | 205 | $2,913 |
| Atorvastatin Calcium | 238 | $2,737 |
| Omeprazole | 86 | $1,623 |
| Losartan Potassium | 148 | $1,582 |
| Duloxetine Hcl | 38 | $1,573 |
| PaxlovidNirmatrelvir/Ritonavir | 13 | $1,429 |
| Lisinopril | 163 | $1,266 |
| Amlodipine Besylate | 139 | $1,254 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $758 | $37,21044 claims |
| Novo NordiskOzempic | $301 | $36,19335 claims |
| AstraZenecaFarxiga | $477 | $10,76313 claims |
| Boehringer IngelheimSpiriva Respimat | $192 | $6,43112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,756 physician assistant providers in Oregon.
Other physician assistant in Springfield
- Devon ParksEugene$62K
- Ryan CainCorvallis$55K
- Sean BrownPortland$43K
- Pooja PatelWoodburn$41K
- Meegan MangumPortland$25K
- Scott FrazeePortland$24K
- Marissa ReenEugene$15K
- Debra Allen KutcherMedford$14K
- Hanna TynerBend$12K
- Amanda VansantEugene$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.